Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2011 Jan;57(1):101–112. doi: 10.1053/j.ajkd.2010.08.021

Table 4.

Univariate and Case-Mix–Adjusted Regression Analysis of Physical Function Score

Univariate Results
Case-Mix–Adjusted Results
Variables No. Estimate (95% CI) P Estimate (95% CI) P
Age (/decade) 375
 ≤50 y −8.90 (−12.5 to −5.24) <0.001 −9.13 (−12.7 to −5.49) <0.001
 >50 y −0.34 (−3.86 to 3.18) 0.9 −0.09 (−3.59 to 3.41) 0.9
Male 375 8.37 (2.98 to 13.7) 0.002 8.66 (3.44 to 13.8) 0.001
Black race 375 −1.83 (−7.28 to 3.62) 0.5 −0.44 (−5.68 to 4.80) 0.9
ESRD vintage (y) 375 0.32 (−0.12 to 0.76) 0.1 0.25 (−0.18 to 0.67) 0.3
Primary language not English 375 6.69 (−0.36 to 13.7) 0.06 4.77 (−2.36 to 11.9) 0.2
Education levela 372
 <High school graduate 1.61 (−5.45 to 8.68) 0.7 −0.67 (−7.52 to 6.17) 0.8
 High school graduate 2.50 (−4.04 to 9.05) 0.5 1.81 (−4.45 to 8.08) 0.5
Does not live with family vs lives with family 372 4.23 (−1.80 to 10.2) 0.2 4.37 (−1.49 to 10.2) 0.1
Insurance statusb 372
 Employer group health insurance or privately
  purchased
−0.75 (−7.51 to 6.02) 0.8 0.71 (−5.78 to 7.20) 0.8
 Government insurance for the poorc 1.56 (−4.48 to 7.95) 0.6 −0.11 (−6.37 to 6.16) 0.9
Diabetes 370 −19.2 (−24.2 to −14.1) <0.001 −16.3 (−21.5 to −11.0) <0.001
Congestive heart failure 370 −9.81 (−16.6 to −3.01) 0.005 −5.45 (−12.2 to 1.31) 0.1
Peripheral arterial disease 370 −24.2 (−32.0 to −16.4) <0.001 −22.9 (−30.6 to −15.3) <0.001
Stroke 370 −18.5 (−28.8 to −8.20) <0.001 −13.7 (−23.7 to −3.70) 0.008
enPCR (0.1 g/kg/d) 371 1.17 (0.20 to 2.14) 0.02 1.35 (0.40 to 2.31) 0.005
Residual renal clearance (mL/min) 372 4.39 (−1.89 to 310.0) 0.2 0.76 (−0.78 to 2.29) 0.3
Creatinine (mg/dL) 372 2.26 (1.39 to 3.14) <0.001 1.80 (0.84 to 2.75) <0.001
Phosphate (mg/dL) 372 1.46 (−0.11 to 3.04) 0.07 0.73 (−0.85 to 2.31) 0.4
Hemoglobin (g/dL) 346 2.69 (0.54 to 4.84) 0.01 2.42 (0.35 to 4.48) 0.02
PTH (0.1 pg/L) 364 1.93 (−0.96 to 192.0) 0.6 0.19 (−0.47 to 0.86) 0.6
Albumin (g/dL) 372 1.16 (0.55 to 1.76) <0.001 0.96 (0.37 to 1.55) 0.002
Calcium (mg/dL) 364 1.06 (−2.00 to 4.11) 0.5 2.25 (−0.71 to 5.20) 0.1
Bicarbonate (mmol/L) 363 −0.79 (−1.49 to −0.09) 0.03 −0.59 (−1.27 to 0.09) 0.09
LV mass (10 g) 349 −0.05 (−0.57 to 0.47) 0.8 −0.46 (−1.02 to 0.09) 0.1
BMI (kg/m2) 353 −0.56 (−0.91 to −0.21) 0.002 −0.47 (−0.81 to −0.13) 0.007
ICW volume/weight (dL/kg) 351 11.7 (7.60 to 15.8) <0.001 15.0 (8.18 to 21.9) <0.001
Phase angle (0.1°) 351 0.40 (0.20 to 0.60) <0.001 0.23 (0.04 to 0.43) 0.02
Randomly assigned vs not randomly assigned 375 9.46 (1.60 to 17.3) 0.02 9.66 (2.15 to 17.1) 0.01
Nocturnal vs daily trial 375 2.41 (−3.67 to 8.50) 0.4 2.76 (−3.11 to 8.63) 0.4

Note: Physical Functioning is composed of 10 questions about mobility (moving a table, pushing a vacuum, lifting or carrying groceries, climbing several flights of stairs, climbing 1 flight of stairs, bending or stooping, walking 1 mile, walking several blocks, and walking 1 block) and self-care (bathing or dressing oneself).

Abbreviations: BMI, body mass index; CI, confidence interval; enPCR, equilibrated normalized protein catabolic rate; ESRD, end-stage renal disease; ICW, intracellular water; LV, left ventricular; PTH, parathyroid hormone.

a

The reference group is individuals with education beyond high school.

b

The reference group is government insurance not awarded by income level (Medicare plus Canadian Health).

c

Medicaid and/or other state/county programs.